ImmuONE

ImmuONE is a specialist in respiratory immunology, developing in vitro products and services to help companies assess the safety of inhaled chemicals, particles and products. Since 2013, its researchers have focused on the lung’s innate immune response, particularly the role of alveolar macrophages, which are among the first cells to encounter inhaled substances. ImmuONE’s human-relevant models and multi-endpoint assessments examine cell morphology, function and biochemistry, helping clients understand whether responses are adaptive or potentially adverse.

The company provides contract research and assay development, including inflammation and immune-response testing, alveolar macrophage assessments, inhalation toxicology, and support for drug discovery and development. Its work includes high-content imaging and the morph_ONE assay, which combines cell morphology with cell-health and biochemical readouts. ImmuONE also offers scientific support and consultancy, tailored experimental design, and animal product-free services.

Its patented products ImmuPHAGE and ImmuLUNG enable detailed investigation of lung immune responses, including macrophage and alveolar epithelial responses. ImmuONE’s approaches aim to provide robust, reproducible insights while reducing reliance on animal testing.